UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Trends in pharmacological sciences (Regular ed.), ISSN 0165-6147, 2005, Volume 26, Issue 10, pp. 517 - 525
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Animals | Encephalitis - drug therapy | Immunity, Innate - drug effects | Anti-Inflammatory Agents - pharmacology | Humans | Anti-Inflammatory Agents - therapeutic use | Encephalitis - immunology | Neurodegenerative Diseases - drug therapy | Neurodegenerative Diseases - immunology | Neurodegenerative Diseases - complications | Encephalitis - etiology | Nervous system | Degeneration | Nonsteroidal anti-inflammatory drugs | Research | Antineoplastic agents | Structure-activity relationships | Drug therapy | Multiple sclerosis | Parkinson's disease | Anti-inflammatory drugs | Alzheimer's disease | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 01/2019, Volume 20, Issue 1, pp. e54 - e64
Life Sciences & Biomedicine | Oncology | Science & Technology | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Drug-Related Side Effects and Adverse Reactions - pathology | Immunotherapy - adverse effects | Neoplasms - therapy | Algorithms | Drug-Related Side Effects and Adverse Reactions - immunology | Antineoplastic Agents - adverse effects | Immunosuppressive Agents - adverse effects | Drug-Related Side Effects and Adverse Reactions - drug therapy | Drug-Related Side Effects and Adverse Reactions - physiopathology | Precision Medicine | Index Medicus
Journal Article
Advanced drug delivery reviews, ISSN 0169-409X, 08/2016, Volume 103, pp. 121 - 143
HIV-1 | Antiretroviral drugs | Drug disposition | Blood–tissue barriers | SLC transporter | Nuclear receptors | ABC transporter | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Anti-HIV Agents - administration & dosage | Antiretroviral Therapy, Highly Active | Biological Transport, Active | Animals | Anti-HIV Agents - pharmacokinetics | Humans | HIV Infections - drug therapy | Drug Carriers | Drugs | Highly active antiretroviral therapy | Antiviral agents | Drug delivery systems | HIV (Viruses) | Drug therapy | Health aspects | Vehicles | Drug resistance in microorganisms | Encephalitis | Cysteine | Corticosteroids | Liver | Cytochrome P-450 | World health | Estrogen | Drugstores | Calcifediol | Cystine | Tenofovir | Vitamin D | Protease inhibitors | Proteases | Pharmacy | DNA polymerases | Nucleosides | Alfacalcidol | Index Medicus
Journal Article
2001, Compass series, ISBN 9780309076364, xiii, 122
Book
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 02/2018, Volume 89, Issue 2, pp. 138 - 146
Journal Article | autoimmune encephalitis | autoimmune neurology | meningoencephalitis | astrocytes | autoantibodies | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Surgery | Science & Technology | Meningoencephalitis - physiopathology | Glial Fibrillary Acidic Protein - genetics | Brain - diagnostic imaging | Humans | Middle Aged | Movement Disorders - immunology | Male | Plasma Exchange | Ovarian Neoplasms - complications | Cerebellar Ataxia - immunology | Meningoencephalitis - immunology | Young Adult | Autoimmune Diseases of the Nervous System - physiopathology | Carcinoma - complications | Myelitis - immunology | Immunotherapy | Encephalomyelitis - therapy | Aged, 80 and over | Child | Myoclonus - immunology | Myelitis - physiopathology | Spinal Cord - diagnostic imaging | Autoimmune Diseases of the Nervous System - complications | Mice, Knockout | Myelitis - complications | Magnetic Resonance Imaging | Meningoencephalitis - complications | Cerebellar Ataxia - complications | Cerebellar Ataxia - therapy | Movement Disorders - physiopathology | Drug Resistant Epilepsy - immunology | Immunoglobulins, Intravenous - therapeutic use | Protein Isoforms | Adolescent | Drug Resistant Epilepsy - therapy | Mice | Myoclonus - therapy | Glucocorticoids - therapeutic use | Glial Fibrillary Acidic Protein - immunology | Cerebellar Ataxia - physiopathology | Myoclonus - complications | Encephalomyelitis - complications | Encephalomyelitis - physiopathology | Adult | Female | Optic Neuritis - immunology | Optic Neuritis - complications | Optic Neuritis - therapy | Myoclonus - physiopathology | Movement Disorders - complications | Thymus Neoplasms - complications | Autoimmune Diseases of the Nervous System - immunology | Breast Neoplasms - complications | Autoantibodies - immunology | Drug Resistant Epilepsy - complications | Animals | Movement Disorders - therapy | Optic Neuritis - physiopathology | Encephalomyelitis - immunology | Meningoencephalitis - therapy | Aged | Autoimmune Diseases of the Nervous System - therapy | Myelitis - therapy | Thymoma - complications | Drug Resistant Epilepsy - physiopathology | Immunologic Factors - therapeutic use | Autoimmunity | Usage | Care and treatment | Autoantibodies | Autoimmune diseases | Analysis | Encephalitis | Brain | Antigens | Multiple sclerosis | Immunoglobulins | Spinal cord | Dendritic cells | Disease | Epilepsy | Aquaporins | Cognitive ability | Nervous system | Drug resistance | Patients | Proteins | Immunology | Microscopy | Rheumatoid arthritis | Rodents | Ataxia | Animal cognition | Index Medicus
Journal Article
Experimental neurology, ISSN 0014-4886, 2007, Volume 206, Issue 1, pp. 59 - 69
Interleukin 6 | TNFα | Traumatic brain injury | Cerebral blood flow | Simvastatin | Nitric oxide | Atorvastatin | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Injuries of the nervous system and the skull. Diseases due to physical agents | Neurology | Biological and medical sciences | Medical sciences | Traumas. Diseases due to physical agents | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Cerebrovascular Circulation - physiology | Recovery of Function - drug effects | Male | Brain Injuries - physiopathology | RNA, Messenger - metabolism | Simvastatin - pharmacology | Chemotaxis, Leukocyte - physiology | Encephalitis - physiopathology | Chemotaxis, Leukocyte - drug effects | Anti-Inflammatory Agents - therapeutic use | Recovery of Function - physiology | Neurons - metabolism | Cytokines - genetics | Heptanoic Acids - pharmacology | Disease Models, Animal | Brain Edema - etiology | Anti-Inflammatory Agents - pharmacology | Endothelial Cells - metabolism | Brain Ischemia - physiopathology | Hippocampus - pathology | Cognition Disorders - drug therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Brain Edema - physiopathology | Brain Ischemia - drug therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Mice | Nerve Degeneration - etiology | Hippocampus - physiopathology | Encephalitis - etiology | Simvastatin - therapeutic use | Brain Injuries - drug therapy | Heptanoic Acids - therapeutic use | Nerve Degeneration - physiopathology | Hippocampus - drug effects | Encephalitis - drug therapy | Cognition Disorders - etiology | Neurons - drug effects | Pyrroles - therapeutic use | RNA, Messenger - drug effects | Cognition Disorders - physiopathology | Cerebrovascular Circulation - drug effects | Mice, Inbred C57BL | Treatment Outcome | Brain Ischemia - etiology | Atorvastatin Calcium | Pyrroles - pharmacology | Animals | Brain Edema - drug therapy | Brain Injuries - pathology | Nerve Degeneration - drug therapy | Endothelial Cells - drug effects | Physiological aspects | Brain | Injuries | Blood flow | Index Medicus
Journal Article